InvestorsObserver
×
News Home

Where Does Vincerx Pharma Inc (VINC) Stock Fall in the Biotechnology Field After It Has Gained 26.02% This Week?

Tuesday, May 02, 2023 12:36 PM | InvestorsObserver Analysts

Mentioned in this article

Where Does Vincerx Pharma Inc (VINC) Stock Fall in the Biotechnology Field After It Has Gained 26.02% This Week?

Vincerx Pharma Inc (VINC) is near the middle in its industry group according to InvestorsObserver. VINC gets an overall rating of 55. That means it scores higher than 55 percent of stocks. Vincerx Pharma Inc gets a 63 rank in the Biotechnology industry. Biotechnology is number 29 out of 148 industries.

Overall Score - 55
VINC has an Overall Score of 55. Find out what this means to you and get the rest of the rankings on VINC!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 55 means the stock is more attractive than 55 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Vincerx Pharma Inc Stock Today?

Vincerx Pharma Inc (VINC) stock has gained 5.44% while the S&P 500 is lower by -1.53% as of 12:28 PM on Tuesday, May 2. VINC has risen $0.08 from the previous closing price of $1.47 on volume of 100,397 shares. Over the past year the S&P 500 has fallen -1.23% while VINC is lower by -41.73%. VINC lost -$3.11 per share the over the last 12 months. Click Here to get the full Stock Report for Vincerx Pharma Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App